Workflow
APi (APG)
icon
Search documents
APi Price And Earnings Diverge, Setting Up Strong Buy Rating
Seeking Alpha· 2024-10-15 07:19
APi Group Corporation’s (NYSE: APG ) earnings appear set to grow again in the third and fourth quarters of 2024. But the share price has declined since April 16, when it hit a highRobert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options, mainly covered calls and collars with long stocks. He is a freelance writer, and his projects include a website that provides information for new and intermediate-level mutual fund investors. A resident of Airdrie, Alberta, Canada, Rob ...
Doral Renewables LLC Announces Closing of $400 Million Equity Investment from APG
GlobeNewswire News Room· 2024-09-13 11:00
PHILADELPHIA, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Doral Renewables LLC (”Doral Renewables” or “the Company”), a leading U.S. developer, owner, and operator of renewable energy and storage projects, announced today the closing of a $400 million minority equity investment by Dutch pension APG on behalf of the largest Dutch pension fund ABP. The investment by and partnership with APG will accelerate the development and construction of Doral Renewables’ energy pipeline. As part of the transaction, APG will also ...
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
GlobeNewswire News Room· 2024-08-19 11:00
Interim safety and pharmacokinetic data from Phase 1 healthy volunteers trial anticipated in 2025 Initiation of the first clinical trial of APG777 and APG990 combination expected to commence in 2025 with the potential for greater efficacy in atopic dermatitis and across I&I diseases SAN FRANCISCO and WALTHAM, Mass., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosin ...
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
GlobeNewswire News Room· 2024-08-12 10:30
Continued advancement of pipeline and execution towards expected milestones, including APG777 16-week proof-of-concept data from the Phase 2 Part A trial in 2H 2025, APG808 interim Phase 1 data in 4Q 2024, and APG990 Phase 1 trial initiation in healthy volunteers accelerated to 3Q 2024 APG333, a novel subcutaneous half-life extended anti-TSLP antibody, added to portfolio to provide for potential best-in-class combination efficacy across multiple respiratory indications, expected to enter the clinic in 2025 ...
APi (APG) - 2024 Q2 - Earnings Call Transcript
2024-08-03 18:04
APi Group Corporation (NYSE:APG) Q2 2024 Results Conference Call August 1, 2024 8:30 AM ET Company Participants Adam Fee - Vice President, Investor Relations Russell Becker - President and Chief Executive Officer Kevin Krumm - Executive Vice President and Chief Financial Officer Conference Call Participants Kathryn Thompson - Thompson Research Group Andy Kaplowitz - Citigroup Jack Cauchi - Barclays Jon Tanwanteng - CJS Securities Stephanie Moore - Jefferies Josh Chan - UBS Charles Tusa - JPMorgan David Paig ...
APi (APG) - 2024 Q2 - Quarterly Report
2024-08-01 16:36
Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share APG New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-Q ___________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, ...
APi (APG) Q2 Earnings Beat Estimates
ZACKS· 2024-08-01 13:51
APi (APG) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.26%. A quarter ago, it was expected that this company would post earnings of $0.32 per share when it actually produced earnings of $0.34, delivering a surprise of 6.25%.Over the last four quarters, the company has surpassed c ...
APi (APG) - 2024 Q2 - Quarterly Results
2024-08-01 11:38
Exhibit 99.1 APi Group Reports Second Quarter 2024 Financial Results -Second quarter net revenues of $1.7 billion, with continued double-digit inspection growth- -Record second quarter net income of $69 million, representing year-over-year growth of 44%- -Record second quarter adjusted EBITDA of $231 million, representing year-over-year growth of 14%- -Record second quarter free cash flow generation, with strong conversion-New Brighton, Minnesota – August 1, 2024 – APi Group Corporation (NYSE: APG) ("APi" o ...
Greystone Capital Q2 2024 Letter To Clients
Seeking Alpha· 2024-07-30 07:45
onuma Inthapong Clients and Friends, During the second quarter of 2024, returns for separate accounts managed by Greystone Capital ranged from +4.3 to +7.1%. The median account return was +6.0%. Year-to-date, the median account return was +6.3%, net of fees. Second quarter and year-to-date results compare both unfavorably and favorably to the S&P 500 and Russell 2000 returns of +4.3% and -3.3% during the quarter and +15.2% and +1.7% year-to-date. Because client portfolios are invested in a concentrated way ...
APG or ULS: Which Is the Better Value Stock Right Now?
ZACKS· 2024-07-09 16:45
Investors interested in Business - Services stocks are likely familiar with APi (APG) and UL Solutions Inc. (ULS) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with positive earnings esti ...